Compare DFIN & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DFIN | PLSE |
|---|---|---|
| Founded | 1983 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 2016 |
| Metric | DFIN | PLSE |
|---|---|---|
| Price | $38.85 | $23.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $61.50 | $22.00 |
| AVG Volume (30 Days) | 276.6K | ★ 438.0K |
| Earning Date | 02-17-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $750,800,000.00 | $86,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.20 | $1,057.59 |
| P/E Ratio | $34.86 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $37.07 | $12.56 |
| 52 Week High | $67.18 | $26.30 |
| Indicator | DFIN | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 21.24 | 70.99 |
| Support Level | $46.04 | $22.67 |
| Resistance Level | $48.80 | $26.30 |
| Average True Range (ATR) | 2.30 | 1.88 |
| MACD | -1.61 | 1.08 |
| Stochastic Oscillator | 1.23 | 81.38 |
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.